Nav: Home

Oral contraceptive use not linked to major birth defects

January 06, 2016

Oral contraceptive use just before or during pregnancy is not associated with an increased risk of major birth defects, suggest the findings of a study published in The BMJ this week.

Oral contraceptives are a leading form of contraception worldwide. When used properly, these are over 99% effective.

However, around 9% of women become pregnant in the first year of use because of missing a dose, taking the pill with other medications, or illnesses.

When planning a pregnancy, most women stop using oral contraceptives, and usually become pregnant within a few months.

Despite decades of research on the safety of oral contraceptive use, little is known about the association between these drugs that contain sex hormones, and major birth defects, especially among these women who become pregnant while taking the drug or after recently stopping use.

So a team of US and Danish researchers carried out a large prospective observational study to examine the association between oral contraceptive use around the time of conception, and into pregnancy, with major birth defects.

All live births, birth defects, and maternal medical conditions were analysed from several national Danish medical registries between 1997 and 2011.

The final analyses included 880,694 liveborn infants, 2.5% of whom had a major birth defect--like an orofacial cleft or limb defect--within the first year of life

Infants with birth defects with known causes, such as fetal alcohol syndrome, or chromosomal aberrations, were excluded.

Recent oral contraceptive use less than three months before the pregnancy or use during early pregnancy were analysed based on prescription information from a national registry.

In total, 68% of mothers used oral contraceptives, but stopped more than three months before pregnancy, and 21% never used oral contraceptives.

Overall, 8% recently stopped using oral contraceptives within 0-3 months before pregnancy, and 1% used oral contraceptives beyond pregnancy--both these categories were analysed as exposed.

Findings from the study revealed no increased risk of any major birth defect associated with oral contraceptive exposure.

The prevalence of major birth defects, per 1000 births, was consistent across each group: 25.1 for never users, 25.0 for oral contraceptive use more than three months before pregnancy, 24.9 for oral contraceptive use within 0-3 months before pregnancy, and 24.8% for oral contraceptive use after pregnancy.

Other risk factors for birth defects and those that increase the likelihood of contraceptive use were adjusted for.

These factors included age at pregnancy, place of birth, level of education, household income, history of birth defects from previous pregnancies, smoking in pregnancy, and healthcare use such as prescription drug use and hospital admissions.

This is an observational study so no definitive conclusions can be made about cause and effect.

Nevertheless, the authors say the findings should reassure "women who have a breakthrough pregnancy during oral contraceptive use or even [those who] intentionally become pregnant within a few months of stopping oral contraceptive use [because] any exposure is unlikely to cause her fetus to develop a major birth defect."


Related Pregnancy Articles:

Paracetamol during pregnancy can inhibit masculinity
Paracetamol during pregnancy can inhibit masculinity Paracetamol during pregnancy can inhibit the development of 'male behavior' in mice.
The cost of opioid use during pregnancy
A new study published today by the scientific journal Addiction reveals that the incidence of neonatal abstinence syndrome -- often caused by mothers using opioids during pregnancy -- is increasing in the United States, and carries an enormous burden in terms of hospital days and costs.
New study: Pre-pregnancy BMI directly linked to excess pregnancy weight gain
It's well known that excessive weight gain during pregnancy can have a lasting negative impact on the health of a mother and her baby.
Pregnancy-specific β1-glycoproteins
Development of new strategies and novel drug design to treat trophoblastic diseases and to provide pregnancy success are of crucial importance in maintenance the female reproductive health.
Should hypothyroidism in pregnancy be treated?
When a woman becomes pregnant, many changes occur in her body.
More Pregnancy News and Pregnancy Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...